Product Information
Name:LGD-6972
Brand:Biosynth
Description:LGD-6972 is a molecule that binds to the drug target of metformin, which is an oral anti-diabetic drug. LGD-6972 has shown that it can reduce hyperglycemia and insulin resistance in rats, as well as decrease blood pressure in mice. LGD-6972 has also been shown to be safe in a clinical study with patients with type 2 diabetes. This compound will be used as an oral treatment for type 2 diabetes and is currently undergoing phase 1 clinical trials.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:702.9 g/mol
Formula:C43H46N2O5S
Purity:Min. 95%
Technical inquiry about: LGD-6972
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.